These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 16970601

  • 1. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
    Itsui Y, Sakamoto N, Kurosaki M, Kanazawa N, Tanabe Y, Koyama T, Takeda Y, Nakagawa M, Kakinuma S, Sekine Y, Maekawa S, Enomoto N, Watanabe M.
    J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells.
    Fillebeen C, Muckenthaler M, Andriopoulos B, Bisaillon M, Mounir Z, Hentze MW, Koromilas AE, Pantopoulos K.
    J Hepatol; 2007 Jul; 47(1):12-22. PubMed ID: 17399844
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [Abstract] [Full Text] [Related]

  • 5. [Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].
    Jia YT, Wei L, Jiang D, Cong X, Fei R.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 03; 85(29):2065-9. PubMed ID: 16313804
    [Abstract] [Full Text] [Related]

  • 6. Bone morphogenetic protein-7 and interferon-alpha synergistically suppress hepatitis C virus replicon.
    Sakamoto N, Yoshimura M, Kimura T, Toyama K, Sekine-Osajima Y, Watanabe M, Muramatsu M.
    Biochem Biophys Res Commun; 2007 Jun 01; 357(2):467-73. PubMed ID: 17433261
    [Abstract] [Full Text] [Related]

  • 7. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH, Kato N, Muroyama R, Taniguchi H, Guleng B, Dharel N, Shao RX, Tateishi K, Jazag A, Kawabe T, Omata M.
    Liver Int; 2010 Feb 01; 30(2):311-8. PubMed ID: 19840259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.
    Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, Szczeponek A, Gerken G, Schlaak JF.
    J Hepatol; 2008 Jun 01; 48(6):914-22. PubMed ID: 18362039
    [Abstract] [Full Text] [Related]

  • 10. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
    Horscroft N, Bellows D, Ansari I, Lai VC, Dempsey S, Liang D, Donis R, Zhong W, Hong Z.
    J Virol; 2005 Mar 01; 79(5):2788-96. PubMed ID: 15708997
    [Abstract] [Full Text] [Related]

  • 11. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R.
    Hepatology; 2012 Dec 01; 56(6):2082-93. PubMed ID: 22711689
    [Abstract] [Full Text] [Related]

  • 12. cDNA microarray analysis to compare HCV subgenomic replicon cells with their cured cells.
    Abe K, Ikeda M, Dansako H, Naka K, Shimotohno K, Kato N.
    Virus Res; 2005 Jan 01; 107(1):73-81. PubMed ID: 15567036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Dharel N, Kato N, Muroyama R, Taniguchi H, Otsuka M, Wang Y, Jazag A, Shao RX, Chang JH, Adler MK, Kawabe T, Omata M.
    Hepatology; 2008 Apr 01; 47(4):1136-49. PubMed ID: 18220274
    [Abstract] [Full Text] [Related]

  • 15. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment.
    Chen L, Sun J, Meng L, Heathcote J, Edwards AM, McGilvray ID.
    J Gen Virol; 2010 Feb 01; 91(Pt 2):382-8. PubMed ID: 19846672
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
    Liu WL, Su WC, Cheng CW, Hwang LH, Wang CC, Chen HL, Chen DS, Lai MY.
    J Infect Dis; 2007 Aug 01; 196(3):425-34. PubMed ID: 17597457
    [Abstract] [Full Text] [Related]

  • 20. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    Kasai D, Adachi T, Deng L, Nagano-Fujii M, Sada K, Ikeda M, Kato N, Ide YH, Shoji I, Hotta H.
    J Hepatol; 2009 May 01; 50(5):883-94. PubMed ID: 19303158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.